HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.

AbstractPURPOSE:
Heparanase activity has been detected in many malignant tumors, showing a correlation with the metastatic potential. The present study was undertaken to investigate the expression of heparanase and its prognostic significance in renal cell carcinomas (RCC).
EXPERIMENTAL DESIGN:
Nineteen RCCs and 6 nonneoplastic renal tissues were analyzed for heparanase mRNA expression by real-time PCR. Heparanase protein expression was semiquantitatively investigated by immunohistochemistry in 70 RCCs. Involvement of heparanase in the invasiveness of RCC cell lines, 786-O and Caki-2 cells, was examined by down-regulating the gene expression with small interfering RNA (siRNA) using the Matrigel invasion assay.
RESULTS:
The expression level of heparanase mRNA was significantly higher in clear cell RCCs than in papillary RCCs, chromophobe RCCs, and nonneoplastic renal tissues. Heparanase was predominantly immunolocalized to cell surface and cytoplasm of clear cell RCCs and mean expression levels of heparanase were significantly higher in clear cell RCCs than in papillary and chromophobe RCCs. The protein expression levels were positively correlated with primary tumor stage, distant metastasis, and histologic grade. Targeting of heparanase mRNA expression in 786-O and Caki-2 cells with siRNA down-regulated the mRNA expression and inhibited the Matrigel invasion by these cells, whereas nonsilencing siRNA showed no effect. Multivariate Cox analysis revealed that elevated heparanase expression was a significant and an independent predictor of disease-specific survival (odds ratio, 8.814; P = 0.019).
CONCLUSIONS:
These data suggest that heparanase plays an important role in invasion and metastasis and silencing of the gene might be a potential therapeutic target in clear cell RCCs.
AuthorsShuji Mikami, Mototsugu Oya, Masayuki Shimoda, Ryuichi Mizuno, Masaru Ishida, Takeo Kosaka, Makio Mukai, Motowo Nakajima, Yasunori Okada
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 14 Issue 19 Pg. 6055-61 (Oct 01 2008) ISSN: 1078-0432 [Print] United States
PMID18809970 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • heparanase
  • Glucuronidase
Topics
  • Aged
  • Carcinoma, Renal Cell (enzymology)
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Glucuronidase (biosynthesis, physiology)
  • Humans
  • Kidney Neoplasms (enzymology)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: